ND-322

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameND-322
Drug Alias NameMT1-MMP/MMP2 inhibitor (Case Western Reserve University)ND-322
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 14 inhibitorsMatrix metalloproteinase-2 inhibitors
TargetsMatrix metalloproteinase 14Matrix metalloproteinase-2
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCase Western Reserve University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCase Western Reserve University
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A